Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 12-19 , July 2004

Delta creatine kinase–MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non–ST-segment elevation acute coronary syndromes

Received 2 October 2003 ,Revised 5 February 2004 ,Accepted 6 February 2004.

References 

  1. National Academy of Clinical Biochemistry Standards of Laboratory Practice . Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem. 1999;45:1104–1121
  2. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med. 1999;37:1097–1106
  3. Newby LK, Storrow AB, Gibler WB, et al.  Bedside multimarker testing for risk stratification in chest pain units. Circulation. 2001;103:1832–1837
  4. Ng SM, Krishnaswamy P, Morissey R, et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611–617
  5. McCord J, Nowak RM, McCullough PA, et al.  Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483–1488
  6. The Joint European Society of Cardiology/American College of Cardiology Committee . Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–969
  7. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J. 2002;144:981–986
  8. Newby LK, Alpert JS, Ohman EM, et al.  Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J. 2002;144:957–980
  9. Ferguson JL, Beckett GJ, Walker SW, et al.  Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction. Heart. 2002;88:343–347
  10. Kontos MC, Fritz LM, Anderson FP, et al.  Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446–452
  11. Fesmire FM, Percy RF, Bardonner JB, et al.  Serial CK-MB testing during the emergency department evaluation of chest pain: utility of a 2 hour delta CK-MB of +1.6 ng/ml. Am Heart J. 1998;136:237–244
  12. Fesmire FM. Delta CK-MB outperforms delta Troponin I at 2 hours during the initial ED evaluation of chest pain. Am J Emerg Med. 2000;18:1–8
  13. Tucker JF, Collins RA, Anderson AJ, et al.  Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction. Ann Emerg Med. 1994;24:704–708
  14. Davis CP, Barrett K, Torre P, et al.  Serial myoglobin levels for patients with possible myocardial infarction. Acad Emerg Med. 1996;3:590–597
  15. Brogan GX, Friedman S, McCuskey C, et al.  Evaluation of a new rapid quantitative immunoassay for serum myoglobin versus CK-MB for ruling out acute myocardial infarction in the emergency department. Ann Emerg Med. 1994;24:665–671
  16. Fesmire FM, Hughes AD, Fody EP, et al.  The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes. Ann Emerg Med. 2002;40:584–594
  17. Abbott Laboratories . Abbott Technical Bulletin: Abbott Axsym System CK-MB. Abbott Park, IL: Abbott Laboratories; 1997; List No. 7A57
  18. Abbott Laboratories . Abbott Technical Bulletin: Abbott Axsym System Myoglobin. Abbott Park, IL: Abbott Laboratories; 1997; List No. 3E43
  19. Abbott Laboratories . Abbott Technical Bulletin: Abbott Axsym System Troponin-I. Abbott Park, IL: Abbott Laboratories; 1997; List No. 3C29
  20. Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350–356
  21. Fesmire FM, Percy RF, Wears RL, et al.  Initial ECG in Q wave and non-Q wave myocardial infarction. Ann Emerg Med. 1989;18:741–746
  22. Schoonjans F, Zalata A, Depuydt CE, et al.  Medcalc: a new computer program for medical statistics. Comput Methods Prog Biomed. 1995;48:257–262
  23. Gallagher EJ. Clinical utility of likelihood ratios. Ann Emerg Med. 1998;31:391–397
  24. Hanley JA, McNeil BJ. A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
  25. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed.. New York, NY: John Wiley & Sons; 1981; 112–119
  26. Kleinbaum DG, Kupper LL, Morganstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publications; 1982; 300–302
  27. McCord J, Nowak RM, Hudson MP, et al.  The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndromes. Ann Emerg Med. 2003;42:343–350

 Author contributions: FMF conceived the study and obtained research funding. All authors were involved in conception and design of the study. FMF and RHC were responsible for analysis and interpretation of data. FMF drafted the manuscript, and all authors contributed substantially to its revision. FMF takes responsibility for the paper as a whole.

☆☆ Presented at the American College of Emergency Physicians Research Forum, Seattle, WA, October 15, 2002.

 Supported by unrestricted research grants from Phillips Medical Systems (formerly Hewlett-Packard), Millennium Pharmaceuticals Inc. (formerly Cor Therapeutics), Bristol-Myers Squibb Medical Imaging (formerly DuPont RadioPharmaceuticals), and EmCare, Inc.

★★ Reprints not available from the authors.

PII: S0196-0644(04)00094-0

doi: 10.1016/j.annemergmed.2004.02.003

Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 12-19 , July 2004